APA (7th ed.) Citation

Storebø, O. J., Pedersen, N., Ramstad, E., Kielsholm, M. L., Nielsen, S. S., Krogh, H. B., . . . Gluud, C. (2018). Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies. Cochrane database of systematic reviews, 5, CD012069. https://doi.org/10.1002/14651858.CD012069.pub2

Chicago Style (17th ed.) Citation

Storebø, Ole Jakob, et al. "Methylphenidate for Attention Deficit Hyperactivity Disorder (ADHD) in Children and Adolescents - Assessment of Adverse Events in Non-randomised Studies." Cochrane Database of Systematic Reviews 5 (2018): CD012069. https://doi.org/10.1002/14651858.CD012069.pub2.

MLA (9th ed.) Citation

Storebø, Ole Jakob, et al. "Methylphenidate for Attention Deficit Hyperactivity Disorder (ADHD) in Children and Adolescents - Assessment of Adverse Events in Non-randomised Studies." Cochrane Database of Systematic Reviews, vol. 5, 2018, p. CD012069, https://doi.org/10.1002/14651858.CD012069.pub2.